Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 19, 2022

Accession no.
0001209191-22-046894
Filed
Aug 19, 2022
Trade date
Jul 1-Aug 15, 2022
Filing delay
49 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 28 non-derivative transactions. Open-market purchases total $8.24K. It was filed 49 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2022Common StockPPurchaseAcquired+130$2.11+$274.3190,464Direct
Jul 5, 2022Common StockPPurchaseAcquired+144$2.18+$313.92190,608Direct
Jul 6, 2022Common StockPPurchaseAcquired+144$2.11+$303.84190,752Direct
Jul 7, 2022Common StockPPurchaseAcquired+144$2.18+$313.92190,896Direct
Jul 8, 2022Common StockPPurchaseAcquired+144$2.19+$315.36191,040Direct
Jul 12, 2022Common StockPPurchaseAcquired+144$2.25+$324191,184Direct
Jul 14, 2022Common StockPPurchaseAcquired+144$2.28+$328.32191,328Direct
Jul 15, 2022Common StockPPurchaseAcquired+144$2.23+$321.12191,472Direct
Jul 18, 2022Common StockPPurchaseAcquired+124$2.41+$298.84191,596Direct
Jul 19, 2022Common StockPPurchaseAcquired+124$2.47+$306.28191,720Direct
Jul 20, 2022Common StockPPurchaseAcquired+124$2.52+$312.48191,844Direct
Jul 21, 2022Common StockPPurchaseAcquired+124$2.54+$314.96191,968Direct
Jul 22, 2022Common StockPPurchaseAcquired+124$2.53+$313.72192,092Direct
Jul 25, 2022Common StockPPurchaseAcquired+124$2.48+$307.52192,216Direct
Jul 26, 2022Common StockPPurchaseAcquired+124$2.47+$306.28192,340Direct
Jul 27, 2022Common StockPPurchaseAcquired+90$2.36+$212.4192,430Direct
Jul 28, 2022Common StockPPurchaseAcquired+124$2.28+$282.72192,554Direct
Jul 29, 2022Common StockPPurchaseAcquired+124$2.28+$282.72192,678Direct
Aug 1, 2022Common StockPPurchaseAcquired+124$2.34+$290.16192,802Direct
Aug 3, 2022Common StockPPurchaseAcquired+50$2.45+$122.5192,852Direct
Aug 4, 2022Common StockPPurchaseAcquired+124$2.17+$269.08192,976Direct
Aug 5, 2022Common StockPPurchaseAcquired+124$2.12+$262.88193,100Direct
Aug 8, 2022Common StockPPurchaseAcquired+138$2.19+$302.22193,238Direct
Aug 9, 2022Common StockPPurchaseAcquired+138$2.19+$302.22193,376Direct
Aug 10, 2022Common StockPPurchaseAcquired+138$2.19+$302.22193,514Direct
Aug 11, 2022Common StockPPurchaseAcquired+138$2.46+$339.48193,652Direct
Aug 12, 2022Common StockPPurchaseAcquired+138$2.52+$347.76193,790Direct
Aug 15, 2022Common StockPPurchaseAcquired+110$2.45+$269.5193,900Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)